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Background: The genotoxic effect of cigarette smoke is routinely measured by treating cells with cigarette
Particulate Matter (PM) at different dose levels in submerged cell cultures. However, PM exposure cannot be
considered as a complete exposure as it does not contain the gas phase component of the cigarette smoke. The
in vitro γH2AX assay by High Content Screening (HCS) has been suggested as a complementary tool to the
standard battery of genotoxicity assays as it detects DNA double strand breaks in a high-throughput fashion. The
aim of this study was to further optimise the in vitro γH2AX assay by HCS to enable aerosol exposure of human
bronchial epithelial BEAS-2B cells at the air-liquid interface (ALI).
Methods: Whole mainstream cigarette smoke (WMCS) from two reference cigarettes (3R4F and M4A) were assessed
for their genotoxic potential. During the study, a further characterisation of the Borgwaldt RM20S® aerosol exposure
system to include single dilution assessment with a reference gas was also carried out.
Results: The results of the optimisation showed that both reference cigarettes produced a positive genotoxic response
at all dilutions tested. However, the correlation between dose and response was low for both 3R4F and M4A (Pearson
coefficient, r = −0.53 and −0.44 respectively). During the additional characterisation of the exposure system, it was
observed that several pre-programmed dilutions did not perform as expected.
Conclusions: Overall, the in vitro γH2AX assay by HCS could be used to evaluate WMCS in cell cultures at the ALI.
Additionally, the extended characterisation of the exposure system indicates that assessing the performance of the
dilutions could improve the existing routine QC checks.
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Cigarette smoke is a complex aerosol mixture consisting
of more than 6,000 identified compounds that can be di-
vided between the particulate phase, accounting for 4.5%
of the total aerosol mixture mass, and the gas phase, ac-
counting for 95.5% of the total aerosol mixture mass [1].
Testing and understanding the toxicity of cigarette smoke
in vitro is a key step in the characterisation of modified* Correspondence: Carolina_Garcia-Canton@bat.com
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article, unless otherwise stated.tobacco products with potentially reduced harm. Adopting
such strategies are in line with recommendations published
by the Institute of Medicine “Clearing the Smoke” [2] and
the World Health Organisation Framework convention on
Tobacco Control (WHO FCTC) “The scientific basis of to-
bacco product regulation” [3].
Johnson and colleagues published a thorough review on
the in vitro systems used to evaluate the toxicity of
cigarette smoke [4]. In this review, the authors highlighted
that the majority of tobacco-related in vitro toxicology
studies are carried out in non-human cell models which
are poorly validated for tobacco product comparison. They
also concluded that better methods are needed, especiallyCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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in vitro genotoxicity, the authors described that the evalu-
ation of cigarette smoke has been carried out using mainly
cigarette smoke condensate (CSC). However, CSC con-
tains primarily particulate phase components compared to
whole mainstream cigarette smoke (WMCS) which con-
tains both particulate and gas phase components. We con-
sider WMCS a more comprehensive exposure system to
study toxicological effects in vitro (Table 1). Moreover, the
in vitro genotoxicity data has been mainly obtained from
animal-derived cell systems which are functionally very
different from human-derived cells.
There are different in vitro genotoxicity assays that
have been widely used in the assessment of tobacco
products [4]. Some of the assays described such as the
micronucleus or the mouse lymphoma assay focus on
fixed DNA damage like chromosomal damage and mu-
tations, their strengths and limitations have been previ-
ously summarised [7]. The comet assay is the only assay
described by Johnson and colleagues that specifically de-
tects DNA strand breaks. Although the assay is widely
accepted and considered a mature method [8], it does
not discriminate between single or double strand breaks
and has shown high inter- and intra-experimental vari-
ation [9]. The in vitro γH2AX assay, on the other hand,
is an emerging method for DNA damage detection. The
phosphorylation of H2AX (named γH2AX) in responseTable 1 Physical forms of cigarette smoke used in in vitro
testing
Name Description
Cigarette smoke condensate (CSC) Comprises the particulate phase along
with some vapour phase components.
Generated by cold-trapping and
condensation of smoke at extremely
low temperatures. The condensed ‘tar’




Comprises the particulate phase only.
Particulates are typically collected by
passing cigarette smoke through a
Cambridge filter pad and are
subsequently eluted from the filter
pad using a solvent such as
dimethylsulphoxide.
Cigarette smoke extract (CSE) Comprises the particulate phase
along with some vapour phase
components. Generated by bubbling
smoke through a liquid (e.g.




Cells are directly exposed to smoke
at the air-liquid interface. This is more
representative of human exposure
conditions, as cells are exposed to the
gas and vapour phase components in
an aerosol [5].
Table adapted from [6].to DNA double strand breaks (DSB) was first described
in 1998 [10] and has since been extensively investigated
[11]. Some applications in which γH2AX has been used
as a biomarker of DNA damage are pre-clinical drug de-
velopment and clinical studies [12]. More recently,
γH2AX has been suggested as a potential complement
to the current battery of in vitro genotoxicity assays with
applications in the assessment of cigarette smoke [7,13].
The aim of this study was to optimise the novel
in vitro γH2AX assay by High Content Screening (HCS)
that we had previously developed [14], in order to adapt
it for the assessment of aerosols and to evaluate the gen-
otoxic effect of two reference cigarettes in human lung-
derived BEAS-2B cells at the air-liquid interface (ALI).
The optimisation employs the Borgwaldt RM20S® smok-
ing machine (RM20S®) as part of the exposure system
that delivers WMCS to cells at the ALI [5].
The in vitro γH2AX assay has been previously used in
the assessment of cigarette smoke using mainly CSC and
indirect exposure to WMCS i.e. cell cultures that had a
layer of media covering the cells continuously or intermit-
tently during smoke exposure and therefore not consid-
ered true ALI exposure [15-19]. In general, flow cytometry
has been the main method for γH2AX detection and ana-
lysis. In this study, we selected a microscopy-based auto-
mated scoring system known as HCS to acquire and
quantify the γH2AX response after WMCS exposure to
BEAS-2B cells at the ALI. WMCS was tested from two
different cigarettes, 3R4F a reference cigarette from the
University of Kentucky [20] and M4A a historical control
used as internal reference in genotoxicity studies by Brit-
ish American Tobacco [21].
Overall, the results show that the in vitro γH2AX by
HCS can be used as a high throughput tool to assess the
genotoxic effect of WMCS in cultures exposed at the
ALI. The results can be used to compare the genotoxic
responses of different tobacco products. Furthermore,
the optimised in vitro γH2AX assay for aerosol exposure
could be a useful high content screening tool to assess
the genotoxic potential of toxicants in gaseous form.
Methods
Cell culture
The human bronchial epithelial cell line BEAS-2B was
purchased from ATCC (United States). Normal bron-
chial epithelium cells obtained from autopsy of non-
cancerous individuals had been isolated, then infected
with a replication-defective 12-SV40/adenovirus hybrid
(Ad12SV40) and cloned to create an immortalised
phenotype [22]. Cells were seeded into culture vessels
that had been pre-coated with 0.03 mg/mL PureCol® bo-
vine collagen solution (Nutacon, The Netherlands). Cells
were then maintained in Bronchial Epithelial Growth
Medium (BEGM®) at 37°C and 5% CO2 in a humidified
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chial Epithelial Basal Medium with growth supplements
provided in the manufacturer’s BEGM® SingleQuot® kit
(Lonza Group Ltd., Belgium) containing: bovine pituitary
extract, hydrocortisone, human epidermal growth factor,
epinephrine, insulin, triiodothyronine, transferrin, genta-
micin /amphotericin-B and retinoic acid. BEAS-2B cells
were cultured and expanded in-house, the cells were
used between passages 3 and 12 only. All cultures were
negative for mycoplasma. Additionally, the cells were au-
thenticated using the short tandem repeat profiling to
confirm the nature of the cell cultures (LGC Standards,
United Kingdom) [23].
Smoking system
The selection of the RM20S® 8-syringe smoking machine
as the WMCS exposure system was based on previous
in vitro studies [5,24] and thorough evaluations of preci-
sion, accuracy, repeatability and reproducibility [25,26].
The smoking exposure system is schematically repre-
sented in Figure 1. The RM20S® employs a dilution sys-
tem that mixes WMCS with different proportions of air
to generate a dilution ratio represented as 1 : X (smoke
volume : air volume). Cigarettes are automatically loadedFigure 1 Schematic representation of a single RM20S® syringe combi
patent publication WO 03/100417/ A1) (not to scale). The RM20S® can
cigarette in place; [B] 150 mL glass syringe where cigarette smoke dilution
porous membrane inserts with cells seeded on top at the ALI [E] Transwelinto cigarette holders (Figure 1A) where WMCS is drawn
directly into the glass syringe and diluted with air taken
from the laboratory environment (Figure 1B) following a
multi-step process operated by a plunger (Figure 1C). The
diluted WMCS is then delivered to an exposure chamber
(Figure 1D) containing four Transwell® inserts with
BEAS-2B cells seeded on top of the insert’s membrane
(Figure 1E). At the time of the exposure the cells are dir-
ectly exposed to WMCS at the air-liquid interface (ALI).
Dilution performance evaluation
A range of dilutions were selected for this study from
1:25 to 1:20000 (smoke volume : air volume) (Table 2).
The methodology employed by Kaur and colleagues used
methane (CH4) as a reference gas standard with known
parts per million (PPM) to compare syringe performance
and has been adapted here to assess dilution perform-
ance [25]. For our experiments, three different methane
reference standards in nitrogen were purchased from
Air Products PLC (United Kingdom), 10% containing
100,000 PPM methane, 50% containing 500,000 PPM
methane and 99.95% containing 1,000,000 PPM methane.
The relevant reference gas was loaded into a sealed bag
and connected directly to the smoking machine cigarettened with British American Tobacco’s exposure chamber (UK
smoke up to eight cigarettes simultaneously. [A] Cigarette holder with
in air is prepared; [C] Plunger; [D] Exposure chamber containing
l® insert representation. Figure adapted from [26].
Table 2 Range of dilutions, details of methane reference
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programmed into the RM20S® and then gas diluted fol-
lowing International Standard Organization (ISO)
3308:2012 puffing profile consisting of 35 mL puff vol-
ume, 2 sec puff duration, and 60 sec puff interval [27]. A
second empty sealed bag was connected to the exhaust
position in the place of the exposure chamber to collect
the diluted gas (Figure 1D). Quantification of methane in
PPM was performed with a 3010 MINIFID portable
heated flame ionization detector total hydrocarbon ana-
lyser (Signal Group Ltd, United Kingdom) as per manu-
facturer’s instructions. Table 2 summarises details about
dilutions, reference gas standard used per dilution and ex-
pected PPM. The laboratory environment was conditioned
at 22 ± 2°C and 60 ± 5% Relative Humidity (RH).
Smoke exposure
Cigarettes were conditioned for a minimum of 48 hours
prior to use (60 ± 3% relative humidity, 22 ± 1°C accord-
ing to ISO 3402:1999) [28] and smoked continuously
throughout the exposure on a RM20S® smoking machine
(Borgwaldt KC, Germany) using a 35 ml puff volume
drawn over 2 seconds, once every minute according to
ISO 3308:2012 [27]. The smoking environment was con-
ditioned at 22 ± 2°C and 60 ± 5% RH.
In this study two reference cigarettes were used to test
whether the in vitro γH2AX assay by HCS could discrim-
inate between products. The reference cigarette 3R4F sup-
plied by the University of Kentucky, is a “US style”
blended cigarette that delivers 9.4 mg tar and 0.7 mg nico-
tine under ISO conditions for cigarette smoking (ISO
3308:2012) [27]. Internal reference cigarette M4A is a fluecured cigarette that delivers 10 mg of tar and 1.0 mg nico-
tine under ISO conditions for cigarette smoking (ISO
3308:2012) [27].
Controls
Etoposide (1 mM final) was used as a positive control
during the experimentation (Sigma-Aldrich, United
Kingdom). Etoposide is a well-known DNA-damaging
compound and has previously been used in the in vitro
γH2AX assay by HCS as a reference compound and
positive control respectively [14,29]. Two different nega-
tive controls were used in this study; air control and in-
cubator control. The air control was generated by the
smoking machine to evaluate the quality of the air used
to dilute the WMCS and mimic the exposure conditions.
The incubator control evaluated the incubation condi-
tions used to generate the positive controls.
WMCS treatment, γH2AX immunostaining and imaging
analysis
The methodology used during this study to detect and
quantify γH2AX by HCS was previously described [14]
with variations for the ALI exposure. In this study, cells
were seeded on top of the membrane of collagen pre-
coated 24-Transwell® plate (Corning Incorporated Life
Sciences, Unites States) at a concentration of 1.2 × 105
cells/mL and 500 μL of BEGM® were added underneath
to keep the cells hydrated. The plates were then incu-
bated overnight at 37°C in an atmosphere of 5% CO2 in
air. At the time of treatment, the culture media was re-
moved from the Transwell® membrane so the cells could
be exposed directly at the ALI. Then, four inserts were
transferred to each exposure chamber containing 25 mL
of Dulbecco’s Modified Eagle Medium supplemented
with 1% L-Glutamine and 0.5% penicillin/streptomycin
(10000 IU/mL – 10000uG/mL). The exposure chambers
were then placed in an incubator at 37°C and connected
with plastic tubing to the smoking machine as represented
in Figure 1D (smoke in/smoke out connectors). The
smoking machine pre-programmed with the appropriate
dilutions was set for a 3 hour exposure. We selected a
3 hour exposure as it is the minimum recommended in
the International Conference on Harmonisation of Tech-
nical Requirements for Registration of Pharmaceuticals for
Human Use (ICH guidelines) [30]. Following exposure,
the inserts were placed in clean pre-labelled 24-well plates
where the cells were fixed with 4% paraformaldehyde
(100 μL/insert) and incubated for 15 minutes at room
temperature. The fixed samples were processed for γH2AX
immunostaining following manufacturer’s recommendation
(ThermoScientific, United States).
Image acquisition was performed using the Cellomics
ArrayScan® VTI platform (ThermoScientific, USA). Image
analysis used the Target Activation Bioapplication software
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cells per insert, giving a minimum of 2000 cells per con-
centration tested. Nuclear DNA staining (Hoechst dye)
was used to identify viable cells nuclei. These nuclei were
used as the target areas for the measurement of γH2AX
specific fluorescence intensity represented as absolute in-
tensity units. Viable cell counts from negative controls
were defined as 100% cell viability. The viable cell counts
in the WMCS and etoposide treated samples were then
compared to those in the negative control, and the per-
centage cell viability was calculated and referred to as
Relative Cell Counts (RCC).
Data analysis and criteria
Dilution performance evaluation
1-sample t-test was used to compare the results obtained
in PPM for each dilution with the expected PPM. A vari-
ability of ±10% over the expected PPM was included
afterwards as accepted measurement variation [31]. Re-
peatability and Reproducibility statistics were computed
for all data points according to ISO 5725–2:1994 [32].
Experiments were replicated 3 times, with 6 repeats per
dilution per experiment. Data analysis and graphical rep-
resentations were performed with Minitab software v.16.
WMCS genotoxicity evaluation
The evaluation criteria used in this study (Table 3) was first
described by Smart et al. for the analysis of γH2AX by flow
cytometry [13] and recently applied by Garcia-Canton et al.
for the analysis of γH2AX by HCS [14]. Experiments were
replicated at least three times, with 4 repeats per dilution
per experiment and graphical representation was per-
formed using GraphPad Prism software v.6.01.
Results
The Borgwaldt RM20S® smoking machine combined with
British American Tobacco’s chamber were used as an ex-
posure system during the optimisation of the novel in vitro
γH2AX assay by HCS for the evaluation of aerosols.
The initial steps in this optimisation included extend-
ing the QC checks of the RM20S® to include 14 dilution
performance evaluations (Table 2). From the 10 dilutions
generating accurate deliveries, 6 smoke dilutions wereTable 3 Genotoxicity evaluation criteria for the in vitro
γH2AX assay by HCS
γH2AX response Classification
> 1.5-fold γH2AX @ RCC > 25% Genotoxic (+)
< 1.5-fold γH2AX @ RCC 100-0% Non-genotoxic (−)
> 1.5-fold γH2AX @ RCC < 25% “False” positive; Cytotoxic-driven
genotoxicity (C)
1.5-fold γH2AX @ RCC ≥ 25% Equivocal (±)
Table adapted from [13].selected for further experiments based on range finder
experiments (data not shown). The tested smoke dilu-
tions covered a wide range of WMCS dilutions to assess
the genotoxicity effect of two reference cigarettes (3R4F
and M4A).
Dilution performance evaluation
An initial range of 14 dilutions from 1:25 to 1:20,000
were selected to evaluate the actual dilution delivery in
PPM units using reference methane gases (Table 2). The
data in Figure 2 graphically represents the results from
the statistical 1-sample t-test analysis performed com-
paring PPM obtained per dilution (box plot) against the
expected PPM (red dot), the analysis did not incorporate
the ±10% tolerance accepted for machinery measure-
ment variation and was, therefore, added to the expected
PPM value afterwards [31]. Results indicate that in the
majority of the cases (10 out of 14 dilutions) the dilution
delivery was as expected when the ±10% tolerance was
included in the analysis. There were four dilutions where
the statistical analysis (1-sample t-test) showed a statisti-
cally significant difference between measured and ex-
pected PPM (including ±10% measurement variation),
those dilutions are identified in Figure 2 with a hash (#)
(1:1,000, 1:6,000, 1:8,000 and 1:20,000) and were not
taken into consideration for the assessment of WMCS in
the in vitro γH2AX assay.
Figure 3 represents the repeatability and reproducibil-
ity results indicating the precision of the smoking ma-
chine dilution performance within the same experiment
and in different experiments respectively. The repeat-
ability and reproducibility increased linearly with con-
centration as expected.
WMCS genotoxicity assessment
Initial range finder experiments showed that 3 hour expo-
sures to WMCS from 3R4F cigarettes at dilutions more
concentrated than 1:500 produced tar depositions, this
effect was considered equivalent to precipitation. Only di-
lutions greater than 1:500 were included in further experi-
ments. Both reference cigarettes 3R4F and M4A produced
a significant increase in γH2AX frequency (above 1.5-fold
increase) compared to the air-treated control in all the di-
lutions tested (Figure 4). In all experiments the positive
control etoposide produced an increase greater than 1.5-
fold compared to the air-treated control (Figure 4A and B).
Relative Cell Counts (RCC) for all results presented were
above the acceptance limit of toxicity (RCC > 25%) and
therefore no cytotoxic-driven genotoxicity was observed
(Table 3).
Figure 4A illustrates the response produced after 3 hour
exposure to 3R4F WMCS. A variation in the response can
be observed between the most concentrated WMCS
(1:500) and the most diluted WMCS dilution (1:16,000).
Figure 2 Test dilutions t-test boxplots. Expected PPM (red dot), 95% confidence interval from PPM results (blue line). The asterisk (*) indicates
outliers while hash (#) indicates dilutions producing a significant different PPM than expected.
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relation between the dose and the response (Pearson coef-
ficient, r = −0.53). Figure 4B showed the results obtained
after 3 hour exposure to M4A WMCS. In this case, a vari-
ation in the response can only be observed at the most
diluted WMCS dilution tested (1:16,000). The linear re-
gression model produced a low correlation between the
dose and the response (Pearson coefficient r = −0.44).Figure 3 Scatterplot of repeatability (r) (white circle) and
reproducibility (R) (red square).Figure 4C graphically represents the fold-induction results
from both reference cigarettes. In general, 3R4F WMCS
exposure seems to have a more potent genotoxic effect
compared to M4A WMCS exposure, especially at the
most concentrated dilution 1:500.
Discussion
The main objective of this study was to optimise the
novel in vitro γH2AX by HCS for the genotoxicity as-
sessment of aerosols. During the optimisation, the geno-
toxic potential in the form of γH2AX induction from
various dilutions of WMCS of two reference cigarettes
were tested and differences in the response evaluated.
The cell system selected was the BEAS-2B cell line, a
human-derived cell line from the lung, the first target tis-
sue of inhaled aerosols. The non-tumorigenic human-
derived BEAS-2B cell line was isolated from normal hu-
man epithelium and immortalised by virus infection [22].
The normal phenotype and wild-type p53 status support
the use of this cell line in DNA damage studies [33-35].
BEAS-2B cells, however, lack normal metabolic activity
for the majority of cytochrome P450 family, an essential
factor for the phase I bioactivation of some cigarette
smoke toxicants such as 4-(methylnitrosamino)-1-(3-
CA B
Figure 4 γH2AX frequency mean ± SD after 3 h exposure to WMCS from reference cigarette. [A] 3R4F, [B] M4A. Circle (−●-) represents
WMCS results, square (−■-) represents positive control etoposide (1 mM final), triangles (−▼- and -▲-) represents negative controls, air and
incubator controls respectively and dotted red line represents the 1.5-fold increase over the air control indicating the threshold of genotoxic
response. [C] γH2AX fold-induction for both reference cigarettes 3R4F (blue) and M4A (red), dotted line indicates genotoxic level
(>1.5-fold γH2AX response).
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metabolic capability of the cell line would need to be con-
sidered in future experimental designs i.e. including an ex-
ternal source of metabolic activation in part of the
experiments to have a more comprehensive genotoxicity
evaluation of the WMCS.
The Borgwaldt RM20S® smoking machine has been ex-
tensively used for the in vitro evaluation of WMCS
[5,24,37]. Although, some QC analyses have been re-
ported for the accurate performance of the syringes
[25,26] further QC tests for the accurate performance
of the programmed dilutions have proved necessary.
Our results in this study indicate that not all of the pro-
grammed dilutions deliver the expected amount of refer-
ence gas in PPM (Figure 2). We have observed that
more diluted dilutions seem to produce less accurate de-
liveries; this effect could be caused by the smoking ma-
chine dilution programming. The smoking machine
performs a multistep process to dilute WMCS with la-
boratory conditioned air, the process requires the pro-
gramming of more dilution steps for more diluted
dilutions, hence, the potential for more variation. The
discrepancy between expected and delivered aerosol
could affect the exposure to the cell cultures andultimately the outcome of the assay. The same approach
could be applied in the future to the particulate phase
expected in the different dilutions employing Quartz
Crystal Microbalances (QCM) previously described for
this aerosol exposure system [38]. Nevertheless, the
smoking machine performance has shown an overall
good reproducibility and repeatability from dilutions
delivering 50 PPM or above as can be seen in Figure 3.
The performance of syringes and dilutions can be car-
ried out using the same methodology and apparatus
already in place for the standard QC checks. Moreover,
the extended QC check could easily be incorporated
into the routine service of the Borgwaldt RM20S®
smoking machine.
The γH2AX results obtained during the assessment
of two reference cigarettes seem to indicate that the
in vitro γH2AX assay by HCS was able to detect the
genotoxic potential of WMCS, however the correlation
between the dose and the response was low for both ref-
erence cigarettes evaluated in this study across all the
tested dilutions (Figure 4). Nevertheless, the γH2AX re-
sponse obtained after BEAS-2B cells were exposed to a
range of 3R4F WMCS dilutions for 3 hours was in gen-
eral more potent than the response obtained for M4A
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genotoxicity response was primarily associated to the
gas phase we would have expected a better γH2AX
dose–response correlation with the different dilutions
tested. Therefore, we have considered that the particu-
late phase may have a significant effect in driving the
genotoxic potential. This could be further investigated
by characterising the particulates deposited at different
dilution levels with tools such as the QCM balance men-
tioned earlier in this discussion.
It is important to notice that 3 hour continuous expos-
ure as recommended by ICH guidelines [30] could be
the longest exposure time a submerged monolayer cul-
ture might be exposed at the ALI. In our experiments,
the cell cultures were immediately fixed after the expos-
ure to evaluate the DNA damage in the form of γH2AX.
Pilot experiments were conducted where the cell cul-
tures were left to recover for a further 24 hours sub-
merged in media to evaluate potential DNA repair after
the acute 3 hour exposure. The proliferation of the
BEAS-2B cells was greatly affected in WMCS and air
control samples. Interestingly, the same effect was not
observed in incubator control cultures where the humidity
is maintained at a higher level (data not shown). We con-
cluded that for in vitro assays using submerged cultures as
cell systems, 3 hour exposure at the current conditions of
ALI exposure system would cause irreversible damage due
to drying as opposed to aerosol exposure.
Following the optimisation described in this study, fur-
ther investigations employing different exposure times, a
larger number of products and an external source of
metabolic activation would be necessary to support the
applicability of the in vitro γH2AX assay for the evalu-
ation of tobacco products in aerosol exposure. Future
work could also carry out an in-depth characterisation
on the effect that product variations such as different to-
bacco blends have in γH2AX induction to understand
the differences in response.
Nevertheless, the optimisation performed here could
also be applied to the genotoxicity evaluation of other
aerosols such as aerosolised drugs, pollutants and cigarette
smoke toxicants present in the gas phase (e.g. benzene).
Conclusions
Overall, the in vitro γH2AX assay by HCS could be used to
evaluate WMCS in cell cultures at the ALI. Additionally,
the extended characterisation of the exposure system indi-
cates that assessing the performance of the dilutions could
improve the existing routine QC checks.
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